Current and prospective applications of exosomal microRNAs in pulmonary fibrosis (Review)
- Authors:
- Tao Yang
- Jian Wang
- Jiaying Zhao
- Yang Liu
-
Affiliations: Department of Respiratory and Critical Care Medicine, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China, Department of Respiratory and Critical Care Medicine, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China - Published online on: January 24, 2022 https://doi.org/10.3892/ijmm.2022.5092
- Article Number: 37
-
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, et al: Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 198:e44–e68. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lederer DJ and Martinez FJ: Idiopathic pulmonary fibrosis. N Engl J Med. 378:1811–1823. 2018. View Article : Google Scholar | |
|
Schamberger AC, Schiller HB, Fernandez IE, Sterclova M, Heinzelmann K, Hennen E, Hatz R, Behr J, Vašáková M, Mann M, et al: Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease. Sci Rep. 6:299522016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Wang Y, Pandupuspitasari NS, Wu G, Xiang X, Gong Q, Xiong W, Wang CY, Yang P and Ren B: Endoplasmic reticulum stress, a new wrestler, in the pathogenesis of idiopathic pulmonary fibrosis. Am J Transl Res. 9:722–735. 2017. | |
|
Kirby T: Living with idiopathic pulmonary fibrosis. Lancet Respir Med. 9:136–138. 2021. View Article : Google Scholar | |
|
Shenderov K, Collins SL, Powell JD and Horton MR: Immune dysregulation as a driver of idiopathic pulmonary fibrosis. J Clin Invest. 131:e1432262021. View Article : Google Scholar : | |
|
Guenther A, Krauss E, Tello S, Wagner J, Paul B, Kuhn S, Maurer O, Heinemann S, Costabel U, Barbero MAN, et al: The European IPF registry (eurIPFreg): Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis. Respir Res. 19:1412018. View Article : Google Scholar : PubMed/NCBI | |
|
Gao J, Kalafatis D, Carlson L, Pesonen IHA, Li CX, Wheelock Å, Magnusson JM and Sköld CM: Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: A longitudinal analysis of the Swedish IPF Registry. Respir Res. 22:402021. View Article : Google Scholar : | |
|
Maher TM, Costabel U, Glassberg MK, Kondoh Y, Ogura T, Scholand MB, Kardatzke D, Howard M, Olsson J, Neighbors M, et al: Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis. Eur Respir J. 57:19024422021. View Article : Google Scholar : | |
|
Di Martino E, Provenzani A, Vitulo P and Polidori P: Systematic review and meta-analysis of pirfenidone, nintedanib, and pamrevlumab for the treatment of idiopathic pulmonary fibrosis. Ann Pharmacother. 55:723–731. 2021. View Article : Google Scholar | |
|
Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, et al: Effect of recombinant human pentraxin 2 vs placebo on change in forced vital capacity in patients with idiopathic pulmonary fibrosis: A randomized clinical trial. JAMA. 319:2299–2307. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Maher TM, van der Aar EM, Van de Steen O, Allamassey L, Desrivot J, Dupont S, Fagard L, Ford P, Fieuw A and Wuyts W: Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): A phase 2a randomised placebo-controlled trial. Lancet Respir Med. 6:627–635. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Abuserewa ST, Duff R and Becker G: Treatment of idiopathic pulmonary fibrosis. Cureus. 13:e153602021.PubMed/NCBI | |
|
Brigstock DR: Extracellular vesicles in organ fibrosis: Mechanisms, therapies, and diagnostics. Cells. 10:15962021. View Article : Google Scholar : PubMed/NCBI | |
|
Yamada M: Extracellular vesicles: Their emerging roles in the pathogenesis of respiratory diseases. Respir Investig. 59:302–311. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Anderson HC: Vesicles associated with calcification in the matrix of epiphyseal cartilage. J Cell Biol. 41:59–72. 1969. View Article : Google Scholar : PubMed/NCBI | |
|
György B, Szabó TG, Pásztói M, Pál Z, Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A, et al: Membrane vesicles, current state-of-the-art: Emerging role of extracellular vesicles. Cell Mol Life Sci. 68:2667–2688. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Pan BT, Teng K, Wu C, Adam M and Johnstone RM: Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol. 101:942–948. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Menck K, Sivaloganathan S, Bleckmann A and Binder C: Microvesicles in cancer: Small size, large potential. Int J Mol Sci. 21:53732020. View Article : Google Scholar : | |
|
Pegtel DM and Gould SJ: Exosomes. Annu Rev Biochem. 88:487–514. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Cocozza F, Grisard E, Martin-Jaular L, Mathieu M and Théry C: SnapShot: Extracellular vesicles. Cell. 182:262–262.e1. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Freitas D, Kim HS, Fabijanic K, Li Z, Chen H, Mark MT, Molina H, Martin AB, Bojmar L, et al: Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol. 20:332–343. 2018. View Article : Google Scholar : | |
|
Anand S, Samuel M and Mathivanan S: Exomeres: A new member of extracellular vesicles family. Subcell Biochem. 97:89–97. 2021. View Article : Google Scholar | |
|
Kučuk N, Primožič M, Knez Ž and Leitgeb M: Exosomes engineering and their roles as therapy delivery tools, therapeutic targets, and biomarkers. Int J Mol Sci. 22:95432021. View Article : Google Scholar | |
|
Kodam SP and Ullah M: Diagnostic and therapeutic potential of extracellular vesicles. Technol Cancer Res Treat. 20:153303382110412032021. View Article : Google Scholar : PubMed/NCBI | |
|
Shao H, Im H, Castro CM, Breakefield X, Weissleder R and Lee H: New technologies for analysis of extracellular vesicles. Chem Rev. 118:1917–1950. 2018. View Article : Google Scholar : | |
|
Yang D, Zhang W, Zhang H, Zhang F, Chen L, Ma L, Larcher LM, Chen S, Liu N, Zhao Q, et al: Progress opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics. Theranostics. 10:3684–3707. 2020. View Article : Google Scholar | |
|
Théry C, Zitvogel L and Amigorena S: Exosomes: Composition, biogenesis and function. Nat Rev Immunol. 2:569–579. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brügger B and Simons M: Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 319:1244–1247. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
van Niel G, Porto-Carreiro I, Simoes S and Raposo G: Exosomes: A common pathway for a specialized function. J Biochem. 140:13–21. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Vietri M, Radulovic M and Stenmark H: The many functions of ESCRTs. Nat Rev Mol Cell Biol. 21:25–42. 2020. View Article : Google Scholar | |
|
Ju Y, Bai H, Ren L and Zhang L: The role of exosome and the ESCRT pathway on enveloped virus infection. Int J Mol Sci. 22:90602021. View Article : Google Scholar : PubMed/NCBI | |
|
Sun R, Liu Y, Lu M, Ding Q, Wang P, Zhang H, Tian X, Lu P, Meng D, Sun N, et al: ALIX increases protein content and protective function of iPSC-derived exosomes. J Mol Med (Berl). 97:829–844. 2019. View Article : Google Scholar | |
|
Han Q, Lv L, Wei J, Lei X, Lin H, Li G, Cao J, Xie J, Yang W, Wu S, et al: Vps4A mediates the localization and exosome release of β-catenin to inhibit epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett. 457:47–59. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kunadt M, Eckermann K, Stuendl A, Gong J, Russo B, Strauss K, Rai S, Kügler S, Falomir Lockhart L, Schwalbe M, et al: Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation. Acta Neuropathol. 129:695–713. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chang HM and Yeh ETH: SUMO: From bench to bedside. Physiol Rev. 100:1599–1619. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
de Gassart A, Géminard C, Février B, Raposo G and Vidal M: Lipid raft-associated protein sorting in exosomes. Blood. 102:4336–4344. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Rana S and Zöller M: Exosome target cell selection and the importance of exosomal tetraspanins: A hypothesis. Biochem Soc Trans. 39:559–562. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
van Niel G, Charrin S, Simoes S, Romao M, Rochin L, Saftig P, Marks MS, Rubinstein E and Raposo G: The tetraspanin CD63 regulates ESCRT-Independent and -Dependent endosomal sorting during melanogenesis. Dev Cell. 21:708–721. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chairoungdua A, Smith DL, Pochard P, Hull M and Caplan MJ: Exosome release of β-catenin: A novel mechanism that antagonizes Wnt signaling. J Cell Biol. 190:1079–1091. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Doyle LM and Wang MZ: Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 8:7272019. View Article : Google Scholar : | |
|
Dang VD, Jella KK, Ragheb RRT, Denslow ND and Alli AA: Lipidomic and proteomic analysis. of exosomes from mouse cortical collecting duct cells. FASEB J. 31:5399–5408. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
O'Brien K, Breyne K, Ughetto S, Laurent LC and Breakefield XO: RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat Rev Mol Cell Biol. 21:585–606. 2020. View Article : Google Scholar | |
|
Kalluri R and LeBleu VS: The biology, function, and biomedical applications of exosomes. Science. 367:eaau69772020. View Article : Google Scholar : | |
|
Saad MH, Badierah R, Redwan EM and El-Fakharany EM: A comprehensive insight into the role of exosomes in viral infection: Dual faces bearing different functions. Pharmaceutics. 13:14052021. View Article : Google Scholar : | |
|
Gurunathan S, Kang MH, Qasim M, Khan K and Kim JH: Biogenesis, membrane trafficking, functions, and next generation nanotherapeutics medicine of extracellular vesicles. Int J Nanomedicine. 16:3357–3383. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Higginbotham JN, Jeppesen DK, Yang YP, Li W, McKinley ET, Graves-Deal R, Ping J, Britain CM, Dorsett KA, et al: Transfer of functional cargo in exomeres. Cell Rep. 27:940–954.e6. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Krol J, Loedige I and Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 11:597–610. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Mohr AM and Mott JL: Overview of MicroRNA biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 9:654–659. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Shao N, Xue L, Wang R, Luo K, Zhi F and Lan Q: MiR-454-3p is an exosomal biomarker and functions as a tumor suppressor in glioma. Mol Cancer Ther. 18:459–469. 2019. View Article : Google Scholar | |
|
Qiu Y, Li P, Zhang Z and Wu M: Insights into exosomal Non-coding RNAs sorting mechanism and clinical application. Front Oncol. 11:6649042021. View Article : Google Scholar : PubMed/NCBI | |
|
Schirle NT, Sheu-Gruttadauria J and MacRae IJ: Structural basis for microRNA targeting. Science. 346:608–613. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Methods in MicroRNA biogenesis, identification, function and decay. Methods. 152:1–2. 2019. View Article : Google Scholar | |
|
Zhang J, Li S, Li L, Li M, Guo C, Yao J and Mi S: Exosome and exosomal microRNA: Trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 13:17–24. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Guduric-Fuchs J, O'Connor A, Camp B, O'Neill CL, Medina RJ and Simpson DA: Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. BMC Genomics. 13:3572012. View Article : Google Scholar : PubMed/NCBI | |
|
Donzelli J, Proestler E, Riedel A, Nevermann S, Hertel B, Guenther A, Gattenlöhner S, Savai R, Larsson K and Saul MJ: Small extracellular vesicle-derived miR-574-5p regulates PGE2-biosynthesis via TLR7/8 in lung cancer. J Extracell Vesicles. 10:e121432021. View Article : Google Scholar | |
|
Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, et al: Cancer exosomes perform Cell-Independent MicroRNA biogenesis and promote tumorigenesis. Cancer Cell. 26:707–721. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Villarroya-Beltri C, Gutiérrez-Vázquez C, Sánchez-Cabo F, Pérez-Hernández D, Vázquez J, Martin-Cofreces N, Martinez-Herrera DJ, Pascual-Montano A, Mittelbrunn M and Sánchez-Madrid F: Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 4:29802013. View Article : Google Scholar | |
|
Santangelo L, Giurato G, Cicchini C, Montaldo C, Mancone C, Tarallo R, Battistelli C, Alonzi T, Weisz A and Tripodi M: The RNA-Binding Protein SYNCRIP Is a component of the hepatocyte exosomal machinery controlling MicroRNA sorting. Cell Rep. 17:799–808. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Boateng E and Krauss-Etschmann S: miRNAs in lung development and diseases. Int J Mol Sci. 21:27652020. View Article : Google Scholar : | |
|
Bersimbaev R, Aripova A, Bulgakova O, Kussainova A, Akparova A and Izzotti A: The plasma levels of hsa-miR-19b-3p hsa-miR-125b-5p and hsamiR-320c in patients with asthma, COPD and asthma-COPD overlap syndrome (ACOS). MicroRNA. 10:130–138. 2021. View Article : Google Scholar | |
|
Zeng Q and Zeng J: Inhibition of miR-494-3p alleviates oxidative stress-induced cell senescence and inflammation in the primary epithelial cells of COPD patients. Int Immunopharmacol. 92:1070442021. View Article : Google Scholar : PubMed/NCBI | |
|
Weidner J, Bartel S, Kılıç A, Zissler UM, Renz H, Schwarze J, Schmidt-Weber CB, Maes T, Rebane A, Krauss-Etschmann S and Rådinger M: Spotlight on microRNAs in allergy and asthma. Allergy. 76:1661–1678. 2021. View Article : Google Scholar | |
|
Wardzyńska A, Pawełczyk M, Rywaniak J, Makowska J, Jamroz-Brzeska J and Kowalski ML: Circulating miRNA expression in asthmatics is age-related and associated with clinical asthma parameters, respiratory function and systemic inflammation. Respir Res. 22:1772021. View Article : Google Scholar | |
|
Zhong S, Golpon H, Zardo P and Borlak J: MiRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer. Transl Res. 230:164–196. 2021. View Article : Google Scholar | |
|
Cainap C, Balacescu O, Cainap SS and Pop LA: Next generation sequencing technology in lung cancer diagnosis. Biology (Basel). 10:8642021. | |
|
Yang G, Yang L, Wang W, Wang J, Wang J and Xu Z: Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression. Gene. 562:138–144. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Song M, Guo J, Ma J, Qiu M and Yang Z: The function of non-coding RNAs in idiopathic pulmonary fibrosis. Open Med (Wars). 16:481–490. 2021. View Article : Google Scholar | |
|
Wang Q, Xie ZL, Wu Q, Jin ZX, Yang C and Feng J: Role of various imbalances centered on alveolar epithelial cell/fibroblast apoptosis imbalance in the pathogenesis of idiopathic pulmonary fibrosis. Chin Med J (Engl). 134:261–274. 2021. View Article : Google Scholar | |
|
Mao C, Zhang J, Lin S, Jing L, Xiang J, Wang M, Wang B, Xu P, Liu W, Song X and Lv C: Mi RNA -30a inhibits AEC s-II apoptosis by blocking mitochondrial fission dependent on Drp-1. J Cell Mol Med. 18:2404–2416. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Matsushima S and Ishiyama J: MicroRNA-29c regulates apoptosis sensitivity via modulation of the cell-surface death receptor, Fas, in lung fibroblasts. Am J Physiol Lung Cell Mol Physiol. 311:L1050–L1061. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Shetty SK, Tiwari N, Marudamuthu AS, Puthusseri B, Bhandary YP, Fu J, Levin J, Idell S and Shetty S: p53 and miR-34a feedback promotes lung epithelial injury and pulmonary fibrosis. Am J Pathol. 187:1016–1034. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Milanovic M, Fan DNY, Belenki D, Däbritz JHM, Zhao Z, Yu Y, Dörr JR, Dimitrova L, Lenze D, Monteiro Barbosa IA, et al: Senescence-associated reprogramming promotes cancer stemness. Nature. 553:96–100. 2018. View Article : Google Scholar | |
|
Wolters PJ, Collard HR and Jones KD: Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol. 9:157–179. 2014. View Article : Google Scholar : | |
|
Hussen BM, Shoorei H, Mohaqiq M, Dinger ME, Hidayat HJ, Taheri M and Ghafouri-Fard S: The impact of Non-coding RNAs in the epithelial to mesenchymal transition. Front Mol Biosci. 8:6651992021. View Article : Google Scholar : PubMed/NCBI | |
|
Sun J, Li Q, Lian X, Zhu Z, Chen X, Pei W, Li S, Abbas A, Wang Y and Tian L: MicroRNA-29b mediates lung mesenchymal-epithelial transition and prevents lung fibrosis in the silicosis model. Mol Ther Nucleic Acids. 14:20–31. 2019. View Article : Google Scholar | |
|
Qi Y, Zhao A, Yang P, Jin L and Hao C: MiR-34a-5p Attenuates EMT through targeting SMAD4 in silica-induced pulmonary fibrosis. J Cell Mol Med. 24:12219–12224. 2020. View Article : Google Scholar : | |
|
Jeong MH, Kim HR, Park YJ, Chung KH and Kim HS: Reprogrammed lung epithelial cells by decrease of miR-451a in extracellular vesicles contribute to aggravation of pulmonary fibrosis. Cell Biol Toxicol. Aug 30–2021.Epub ahead of print. View Article : Google Scholar | |
|
Liu Y, Nie H, Ding Y, Hou Y, Mao K and Cui Y: MiRNA, a new treatment strategy for pulmonary fibrosis. Curr Drug Targets. 22:793–802. 2021. View Article : Google Scholar | |
|
Rajasekaran S, Rajaguru P and Sudhakar Gandhi PS: MicroRNAs as potential targets for progressive pulmonary fibrosis. Front Pharmacol. 6:2542015. View Article : Google Scholar : PubMed/NCBI | |
|
Wei P, Xie Y, Abel PW, Huang Y, Ma Q, Li L, Hao J, Wolff DW, Wei T and Tu Y: Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis. Cell Death Dis. 10:6702019. View Article : Google Scholar | |
|
Xiao T, Zou Z, Xue J, Syed BM, Sun J, Dai X, Shi M, Li J, Wei S, Tang H, et al: LncRNA H19-mediated M2 polarization of macro-phages promotes myofibroblast differentiation in pulmonary fibrosis induced by arsenic exposure. Environ Pollut. 268(Pt A): 1158102021. View Article : Google Scholar | |
|
Wang P, Xiao T, Li J, Wang D, Sun J, Cheng C, Ma H, Xue J, Li Y, Zhang A and Liu Q: MiR-21 in EVs from pulmonary epithelial cells promotes myofibroblast differentiation via glycolysis in arsenic-induced pulmonary fibrosis. Environ Pollut. 286:1172592021. View Article : Google Scholar : PubMed/NCBI | |
|
Huang Y, Xie Y, Abel PW, Wei P, Plowman J, Toews ML, Strah H, Siddique A, Bailey KL and Tu Y: TGF-β1-induced miR-424 promotes pulmonary myofibroblast differentiation by targeting Slit2 protein expression. Biochem Pharmacol. 180:1141722020. View Article : Google Scholar | |
|
Chen X, Shi C, Wang C, Liu W, Chu Y, Xiang Z, Hu K, Dong P and Han X: The role of miR-97-5p in myofibroblast differentiation of LR-MSCs and pulmonary fibrogenesis. Sci Rep. 7:409582017. View Article : Google Scholar | |
|
Wang C, Gu S, Cao H, Li Z, Xiang Z, Hu K and Han X: MiR-877-3p targets Smad7 and is associated with myofibroblast differentiation and bleomycin-induced lung fibrosis. Sci Rep. 6:301222016. View Article : Google Scholar : PubMed/NCBI | |
|
Akbari Dilmaghnai N, Shoorei H, Sharifi G, Mohaqiq M, Majidpoor J, Dinger ME, Taheri M and Ghafouri-Fard S: Non-coding RNAs modulate function of extracellular matrix proteins. Biomed Pharmacother. 136:1112402021. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Zhang X, Wang T, Li J, Su Q, Zhong C, Chen Z and Liang Y: The MIR155 host gene/microRNA-627/HMGB1/NF-κB loop modulates fibroblast proliferation and extracellular matrix deposition. Life Sci. 269:1190852021. View Article : Google Scholar | |
|
Wang YC, Xie H, Zhang YC, Meng QH, Xiong MM, Jia MW, Peng F and Tang DL: Exosomal miR-107 antagonizes profibrotic phenotypes of pericytes by targeting a pathway involving HIF-1 α/Notch1/PDGFR β/YAP1/Twist1 axis in vitro. Am J Physiol-Heart Circ Physiol. 320:H520–H534. 2021. View Article : Google Scholar | |
|
Phan THG, Paliogiannis P, Nasrallah GK, Giordo R, Eid AH, Fois AG, Zinellu A, Mangoni AA and Pintus G: Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis. Cell Mol Life Sci. 78:2031–2057. 2021. View Article : Google Scholar | |
|
Zhang S, Jia X, Zhang Q, Zhang L, Yang J, Hu C, Shi J, Jiang X, Lu J and Shen H: Neutrophil extracellular traps activate lung fibroblast to induce polymyositis-related interstitial lung diseases via TLR9-miR-7-Smad2 pathway. J Cell Mol Med. 24:1658–1669. 2020. View Article : Google Scholar | |
|
Chen YC, Chen BC, Yu CC, Lin SH and Lin CH: MiR-19a, -19b, and -26b Mediate CTGF expression and pulmonary fibroblast differentiation. J Cell Physiol. 231:2236–2248. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yi M, Liu B, Tang Y, Li F, Qin W and Yuan X: Irradiated human umbilical vein endothelial cells undergo endothelial-mesenchymal transition via the Snail/miR-199a-5p axis to promote the differentiation of fibroblasts into myofibroblasts. Biomed Res Int. 2018:41358062018. View Article : Google Scholar : PubMed/NCBI | |
|
Desai O, Winkler J, Minasyan M and Herzog EL: The role of immune and inflammatory cells in idiopathic pulmonary fibrosis. Front Med (Lausanne). 5:432018. View Article : Google Scholar | |
|
Heukels P, Moor CC, von der Thüsen JH, Wijsenbeek MS and Kool M: Inflammation and immunity in IPF pathogenesis and treatment. Respir Med. 147:79–91. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu M, An Y, Zhang X, Wang Z and Duan H: Experimental pulmonary fibrosis was suppressed by microRNA-506 through NF-kappa-mediated apoptosis and inflammation. Cell Tissue Res. 378:255–265. 2019. View Article : Google Scholar | |
|
Zhou L, Li P, Zhang M, Han B, Chu C, Su X, Li B, Kang H, Ning J, Zhang B, et al: Carbon black nanoparticles induce pulmonary fibrosis through NLRP3 inflammasome pathway modulated by miR-96 targeted FOXO3a. Chemosphere. 241:1250752020. View Article : Google Scholar | |
|
Mo Y, Zhang Y, Wan R, Jiang M, Xu Y and Zhang Q: MiR-21 mediates nickel nanoparticle-induced pulmonary injury and fibrosis. Nanotoxicology. 14:1175–1197. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Tan S and Chen S: The mechanism and effect of autophagy, apoptosis, and pyroptosis on the progression of silicosis. Int J Mol Sci. 22:81102021. View Article : Google Scholar : | |
|
Zhao H, Wang Y, Qiu T, Liu W and Yao P: Autophagy, an important therapeutic target for pulmonary fibrosis diseases. Clin Chim Acta. 502:139–147. 2020. View Article : Google Scholar | |
|
Lv X, Li K and Hu Z: Autophagy and pulmonary fibrosis. Adv Exp Med Biol. 1207:569–579. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Xu T, Yan W, Wu Q, Xu Q, Yuan J, Li Y, Li P, Pan H and Ni C: MiR-326 inhibits inflammation and promotes autophagy in Silica-Induced pulmonary fibrosis through targeting TNFSF14 and PTBP1. Chem Res Toxicol. 32:2192–2203. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Han R, Ji X, Rong R, Li Y, Yao W, Yuan J, Wu Q, Yang J, Yan W, Han L, et al: MiR-449a regulates autophagy to inhibit silica-induced. pulmonary fibrosis through targeting Bcl2. J Mol Med (Berl). 94:1267–1279. 2016. View Article : Google Scholar | |
|
Zareba L, Szymanski J, Homoncik Z and Czystowska-Kuzmicz M: EVs from BALF-Mediators of inflammation and potential biomarkers in lung diseases. Int J Mol Sci. 22:36512021. View Article : Google Scholar : PubMed/NCBI | |
|
Shaba E, Landi C, Carleo A, Vantaggiato L, Paccagnini E, Gentile M, Bianchi L, Lupetti P, Bargagli E, Prasse A and Bini L: Proteome characterization of BALF extracellular vesicles in idiopathic pulmonary fibrosis: Unveiling undercover molecular pathways. Int J Mol Sci. 22:56962021. View Article : Google Scholar : | |
|
Rodríguez M, Silva J, López-Alfonso A, López-Muñiz MB, Peña C, Domínguez G, García JM, López-Gónzalez A, Méndez M, Provencio M, et al: Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer. Genes Chromosomes Cancer. 53:713–724. 2014.PubMed/NCBI | |
|
Liu B, Jiang T, Hu X, Liu Z, Zhao L, Liu H, Liu Z and Ma L: Downregulation of microRNA-30a in bronchoalveolar lavage fluid from idiopathic pulmonary fibrosis patients. Mol Med Rep. 18:5799–5806. 2018.PubMed/NCBI | |
|
Zhu L, Chen Y, Chen M and Wang W: Mechanism of miR-204-5p in exosomes derived from bronchoalveolar lavage fluid on the progression of pulmonary fibrosis via AP1S2. Ann Transl Med. 9:10682021. View Article : Google Scholar : PubMed/NCBI | |
|
Guiot J, Demarche S, Henket M, Paulus V, Graff S, Schleich F, Corhay JL, Louis R and Moermans C: Methodology for Sputum Induction and Laboratory Processing. J Vis Exp. 130:566122017. | |
|
Pastor L, Vera E, Marin JM and Sanz-Rubio D: Extracellular Vesicles from Airway Secretions: New insights in lung diseases. Int J Mol Sci. 22:5832021. View Article : Google Scholar : | |
|
Guiot J, Henket M, Corhay JL, Moermans C and Louis R: Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7. PLoS One. 12:e01713442017. View Article : Google Scholar : PubMed/NCBI | |
|
Njock MS, Guiot J, Henket MA, Nivelles O, Thiry M, Dequiedt F, Corhay JL, Louis RE and Struman I: Sputum exosomes: Promising biomarkers for idiopathic pulmonary fibrosis. Thorax. 74:309–312. 2019. View Article : Google Scholar | |
|
Trappe A, Donnelly SC, McNally P and Coppinger JA: Role of extracellular vesicles in chronic lung disease. Thorax. 76:1047–1056. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Hua Y, Ding Y, Hou Y, Liu Y, Mao K, Cui Y and Nie H: Exosomal MicroRNA: Diagnostic marker and therapeutic tool for lung diseases. Curr Pharm Des. 27:2934–2942. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Minnis P, Kane R, Anglin R, Walsh S, Worrel J, Khan F, Lumsden RV, Whitty S and Keane MP: Serum exosomes from IPF patients display a fibrotic. miRNA profile that correlates to clinical measures of disease severity. Eur Respir Rev. 46(Suppl 59): PA38452015. | |
|
Makiguchi T, Yamada M, Yoshioka Y, Sugiura H, Koarai A, Chiba S, Fujino N, Tojo Y, Ota C, Kubo H, et al: Serum extra-cellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis. Respir Res. 17:1102016. View Article : Google Scholar | |
|
Lacedonia D, Scioscia G, Soccio P, Conese M, Catucci L, Palladino GP, Simone F, Quarato CMI, Di Gioia S, Rana R, et al: Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis. BMC Pulm Med. 21:1882021. View Article : Google Scholar : PubMed/NCBI | |
|
Kuse N, Kamio K, Azuma A, Matsuda K, Inomata M, Usuki J, Morinaga A, Tanaka T, Kashiwada T, Atsumi K, et al: Exosome-derived microRNA-22 ameliorates. pulmonary fibrosis by regulating fibroblast-to-myofibroblast differentiation in vitro and in vivo. J Nippon Med Sch. 87:118–128. 2020. View Article : Google Scholar | |
|
Inomata M, Kamio K, Azuma A, Matsuda K, Usuki J, Morinaga A, Tanaka T, Kashiwada T, Atsumi K, Hayashi H, et al: Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axis. Exp Cell Res. 398:1124162021. View Article : Google Scholar | |
|
Vasse GF, Nizamoglu M, Heijink IH, Schlepütz M, van Rijn P, Thomas MJ, Burgess JK and Melgert BN: Macrophage-stroma interactions in fibrosis: Biochemical, biophysical, and cellular perspectives. J Pathol. 254:344–357. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Kishore A and Petrek M: Roles of macrophage polarization and macrophage-derived. miRNAs in pulmonary fibrosis. Front Immunol. 12:6784572021. View Article : Google Scholar | |
|
Yao MY, Zhang WH, Ma WT, Liu QH, Xing LH and Zhao GF: MicroRNA-328 in. exosomes derived from M2 macrophages exerts a promotive effect on the progression of pulmonary fibrosis via FAM13A in a rat model. Exp Mol Med. 51:1–16. 2019. View Article : Google Scholar | |
|
Wang D, Hao C, Zhang L, Zhang J, Liu S, Li Y, Qu Y, Zhao Y, Huang R, Wei J and Yao W: Exosomal miR-125a-5p derived from silica-exposed. macrophages induces fibroblast transdifferentiation. Ecotoxicol Environ Saf. 192:1102532020. View Article : Google Scholar | |
|
Guiot J, Cambier M, Boeckx A, Henket M, Nivelles O, Gester F, Louis E, Malaise M, Dequiedt F, Louis R, et al: Macrophage-derived exosomes attenuate fibrosis. in airway epithelial cells through delivery of antifibrotic miR-142-3p. Thorax. 75:870–881. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Cruz FF and Rocco PRM: The potential of mesenchymal stem cell therapy for chronic lung disease. Expert Rev Respir Med. 14:31–39. 2020. View Article : Google Scholar | |
|
Yang S, Liu P, Jiang Y, Wang Z, Dai H and Wang C: Therapeutic applications of. mesenchymal stem cells in idiopathic pulmonary fibrosis. Front Cell Dev Biol. 9:6396572021. View Article : Google Scholar | |
|
Ntolios P, Manoloudi E, Tzouvelekis A, Bouros E, Steiropoulos P, Anevlavis S, Bouros D and Froudarakis M: Longitudinal outcomes of patients. Enrolled. in a phase Ib clinical trial of the adipose-derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. Clin Respir J. 12:2084–2089. 2018. View Article : Google Scholar | |
|
Hade MD, Suire CN and Suo Z: Mesenchymal stem cell-derived exosomes: Applications in regenerative medicine. Cells. 10:19592021. View Article : Google Scholar : PubMed/NCBI | |
|
Wan X, Chen S, Fang Y, Zuo W, Cui J and Xie S: Mesenchymal stem cell-derived. extracellular vesicles suppress the fibroblast proliferation by downregulating FZD6 expression in fibroblasts via micrRNA-29b-3p in idiopathic pulmonary fibrosis. J Cell Physiol. 235:8613–8625. 2020. View Article : Google Scholar | |
|
Lei X, He N, Zhu L, Zhou M, Zhang K, Wang C, Huang H, Chen S, Li Y, Liu Q, et al: Mesenchymal stem cell-derived extracellular vesicles Attenuate radiation-induced lung injury via miRNA-214-3p. Antioxid Redox Signal. 35:849–862. 2021. View Article : Google Scholar | |
|
Zhou J, Lin Y, Kang X, Liu Z, Zhang W and Xu F: MicroRNA-186 in extracellular vesicles. from bone marrow mesenchymal stem cells alleviates idiopathic pulmonary fibrosis via interaction with SOX4 and DKK1. Stem Cell Res Ther. 12:962021. View Article : Google Scholar | |
|
Ibrahim A, Ibrahim A and Parimon T: Diagnostic and therapeutic applications of extracellular vesicles in interstitial lung diseases. Diagnostics (Basel). 11:872021. View Article : Google Scholar | |
|
Parimon T, Yao C, Habiel DM, Ge L, Bora SA, Brauer R, Evans CM, Xie T, Alonso-Valenteen F, Medina-Kauwe LK, et al: Syndecan-1 promotes lung fibrosis by. regulating epithelial reprogramming through extracellular vesicles. JCI Insight. 4:e1293592019. View Article : Google Scholar | |
|
Feng Z, Zhou J, Liu Y, Xia R, Li Q, Yan L, Chen Q, Chen X, Jiang Y, Chao G, et al: Epithelium- and endothelium-derived exosomes regulate the. alveolar macrophages by targeting RGS1 mediated calcium signaling-dependent immune response. Cell Death Differ. 28:2238–2256. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Dinh PC, Paudel D, Brochu H, Popowski KD, Gracieux MC, Cores J, Huang K, Hensley MT, Harrell E, Vandergriff AC, et al: Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis. Nat Commun. 11:10642020. View Article : Google Scholar : | |
|
Kadota T, Fujita Y, Araya J, Watanabe N, Fujimoto S, Kawamoto H, Minagawa S, Hara H, Ohtsuka T, Yamamoto Y, et al: Human bronchial epithelial cell-derived. Extracellular. vesicle therapy for pulmonary fibrosis via inhibition of TGF-β-WNT crosstalk. J Extracell Vesicles. 10:e121242021. View Article : Google Scholar | |
|
Liu Z, Yan J, Tong L, Liu S and Zhang Y: The role of exosomes from BALF in lung disease. J Cell Physiol. Aug 13–2021.Epub ahead of print. | |
|
Tieu A, Hu K, Gnyra C, Montroy J, Fergusson DA, Allan DS, Stewart DJ, Thébaud B and Lalu MM: Mesenchymal stromal cell extracellular vesicles as. Therapy. for acute and chronic respiratory diseases: A meta-analysis. J Extracell Vesicles. 10:e121412021. View Article : Google Scholar |
